| Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level Y Wu, S Yang, J Ma, Z Chen, G Song, D Rao, Y Cheng, S Huang, Y Liu, ... Cancer Discovery 12 (1), 134-153, 2022 | 557 | 2022 |
| Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma Z Yang, C Yan, J Ma, P Peng, X Ren, S Cai, X Shen, Y Wu, S Zhang, ... Nature metabolism 5 (1), 61-79, 2023 | 235 | 2023 |
| Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma L Dong, D Lu, R Chen, Y Lin, H Zhu, Z Zhang, S Cai, P Cui, G Song, ... Cancer Cell 40 (1), 70-87.e15, 2022 | 235 | 2022 |
| Correlation between sex and efficacy of immune checkpoint inhibitors (PD‐1 and CTLA‐4 inhibitors) Y Wu, Q Ju, K Jia, J Yu, H Shi, H Wu, M Jiang International Journal of Cancer 143 (1), 45-51, 2018 | 109 | 2018 |
| Spatial omics: Navigating to the golden era of cancer research Y Wu, Y Cheng, X Wang, J Fan, Q Gao Clinical and Translational Medicine 12 (1), e696, 2022 | 104 | 2022 |
| Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma G Song, Y Shi, L Meng, J Ma, S Huang, J Zhang, Y Wu, J Li, Y Lin, S Yang, ... Nature communications 13 (1), 1642, 2022 | 98 | 2022 |
| Pan-cancer analysis reveals disrupted circadian clock associates with T cell exhaustion Y Wu, B Tao, T Zhang, Y Fan, R Mao Frontiers in Immunology 10, 2451, 2019 | 85 | 2019 |
| Neutrophil profiling illuminates anti-tumor antigen-presenting potency Y Wu, J Ma, X Yang, F Nan, T Zhang, S Ji, D Rao, H Feng, K Gao, X Gu, ... Cell 187 (6), 1422-1439. e24, 2024 | 75 | 2024 |
| A blueprint for tumor-infiltrating B cells across human cancers J Ma, Y Wu, L Ma, X Yang, T Zhang, G Song, T Li, K Gao, X Shen, J Lin, ... Science 384 (6695), eadj4857, 2024 | 56 | 2024 |
| A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2 Y Xu#, Y Wu#, S Zhang#, P Ma, X Jin, Z Wang, M Yao, E Zhang, B Tao, ... Cell Reports 29 (11), 3435-3447. e4, 2019 | 52 | 2019 |
| Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology S Ji, L Feng, Z Fu, G Wu, Y Wu, Y Lin, D Lu, Y Song, P Cui, Z Yang, ... Science translational medicine 15 (706), eadg3358, 2023 | 51 | 2023 |
| EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma H Shi, F Yu, Y Mao, Q Ju, Y Wu, W Bai, P Wang, R Xu, M Jiang, J Shi Journal of thoracic disease 10 (5), 2779, 2018 | 47 | 2018 |
| The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta‐analysis of efficacy and safety Y Wu, H Shi, M Jiang, M Qiu, K Jia, T Cao, Y Shang, L Shi, K Jiang, H Wu International Journal of Cancer 141 (12), 2562-2570, 2017 | 40 | 2017 |
| The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages Y Wu, Q Ju, B Qian, F Zhang, H Shi Oncotarget 9 (8), 7942, 2017 | 30 | 2017 |
| Comprehensive transcriptome profiling in elderly cancer patients reveals aging‐altered immune cells and immune checkpoints Y Wu, J Wei, X Chen, Y Qin, R Mao, J Song, Y Fan International Journal of Cancer 144 (7), 1657-1663, 2019 | 29 | 2019 |
| Potential biomarkers for liver cancer diagnosis based on multi-omics strategy F Chen, J Wang, Y Wu, Q Gao, S Zhang Frontiers in Oncology 12, 822449, 2022 | 23 | 2022 |
| Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma Y Wu, J Wei, Y Ming, Z Chen, J Yu, R Mao, H Chen, G Zhou, Y Fan Journal of cellular biochemistry 119 (9), 7696-7706, 2018 | 20 | 2018 |
| C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis H Shi, Y Mao, Q Ju, Y Wu, W Bai, P Wang, Y Zhang, M Jiang International Journal of Oncology 53 (1), 167-176, 2018 | 18 | 2018 |
| HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif Y Wu, H Chen, Y Chen, L Qu, E Zhang, Z Wang, Y Wu, R Yang, R Mao, ... Aging (Albany NY) 11 (8), 2430, 2019 | 17 | 2019 |
| The revolution of lung cancer treatment: from vaccines, to immune checkpoint inhibitors, to chimeric antigen receptor T therapy Y Wu, M Jiang Biotarget 1 (3), 2017 | 17 | 2017 |